Drug-herb interactions.
| Herb . | Drug . | Effect . |
|---|---|---|
| Table modified after reference 17 | ||
| Echinacea | Cyclophosphamide Vinca alkaloids | CYP3A4 induction |
| Essiac | Anthraquinones Others | Inhibition of CYP3A causes synergism with chemotherapy |
| Garlic | Warfarin | Interaction, decreased effect |
| Ginkgo | Cyclophosphamide Vinca alkaloids | CYP3A4 & CYP2C19 inhibition |
| Ginseng | Cyclophosphamide | CYP3A4 inhibition |
| Milk thistle | Doxorubicin | Inhibition of P450 thus decreasing metabolism of doxorubicin |
| St. John’s wort | Cyclosporin Ironotecan Taxanes Imatinib | Subtherapeutic levels of chemotherapeutic agents metabolized by CYP3A4 |
| Herb . | Drug . | Effect . |
|---|---|---|
| Table modified after reference 17 | ||
| Echinacea | Cyclophosphamide Vinca alkaloids | CYP3A4 induction |
| Essiac | Anthraquinones Others | Inhibition of CYP3A causes synergism with chemotherapy |
| Garlic | Warfarin | Interaction, decreased effect |
| Ginkgo | Cyclophosphamide Vinca alkaloids | CYP3A4 & CYP2C19 inhibition |
| Ginseng | Cyclophosphamide | CYP3A4 inhibition |
| Milk thistle | Doxorubicin | Inhibition of P450 thus decreasing metabolism of doxorubicin |
| St. John’s wort | Cyclosporin Ironotecan Taxanes Imatinib | Subtherapeutic levels of chemotherapeutic agents metabolized by CYP3A4 |